DrugPatentWatch Database Preview
Ubrogepant - Generic Drug Details
» See Plans and Pricing
What are the generic sources for ubrogepant and what is the scope of patent protection?
Ubrogepant
is the generic ingredient in one branded drug marketed by Allergan and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ubrogepant has eighty-five patent family members in forty countries.
One supplier is listed for this compound.
Summary for ubrogepant
| International Patents: | 85 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 12 |
| Clinical Trials: | 5 |
| Patent Applications: | 19 |
| DailyMed Link: | ubrogepant at DailyMed |
Recent Clinical Trials for ubrogepant
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Allergan | Phase 1 |
| Allergan | Phase 3 |
US Patents and Regulatory Information for ubrogepant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | UBRELVY | ubrogepant | TABLET;ORAL | 211765-001 | Dec 23, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Allergan | UBRELVY | ubrogepant | TABLET;ORAL | 211765-001 | Dec 23, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Allergan | UBRELVY | ubrogepant | TABLET;ORAL | 211765-002 | Dec 23, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Allergan | UBRELVY | ubrogepant | TABLET;ORAL | 211765-002 | Dec 23, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Y | Start Trial | ||
| Allergan | UBRELVY | ubrogepant | TABLET;ORAL | 211765-001 | Dec 23, 2019 | RX | Yes | No | Start Trial | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ubrogepant
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 190137 | Start Trial |
| Colombia | 6801723 | Start Trial |
| Argentina | 083831 | Start Trial |
| Taiwan | I501968 | Start Trial |
| Guatemala | 201300122 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
